S3v Vascular Technologies Limited

S3v Vascular Technologies Limited - healthcare in Mysore, Karnataka, India. FY 2026 financials & compliance.
CIN U33112KA2011PLC059915 Incorporated 09 August 2011 ROC Bangalore HQ Mysore, Karnataka, India
Active Public Limited Company healthcare
Data last updated
Revenue · FY 2024
₹15.15 Cr
▼ 20% YoY
Net loss · FY 2024
₹3.2 Cr
Net margin -21.1%
EBITDA · FY 2024
₹2.58 Cr
EBITDA margin 17%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹19.18 Cr
Issued & subscribed
Open charges
₹181 Cr
Satisfied ₹23.7 Lakh
Company age
15 yrs
Est. 2011
Employees · EPFO
44
Provident fund records

About S3v Vascular Technologies Limited

Data last updated:

S3v Vascular Technologies Limited is a public limited company based in Mysore, Karnataka, India, recognised as a startup by DPIIT. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 09 August 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U33112KA2011PLC059915. Its GSTIN is 29AAQCS2303F1ZC (Karnataka). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹19.18 Cr. It is led by directors including Vijaya Gopal Nagaradagadde (Managing Director) and Nagarada Gadde Vishnu Shreyas (Whole-Time Director).

Its last annual general meeting (AGM) was held on 29 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 65/D4 Hootagalli Industrial Area Hootagalli, Mysore, Karnataka, India – 570018.

As per the financials filed for FY 2024, the company reported a revenue of ₹15.15 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net loss of ₹3.2 Cr (net margin -21.1%) and EBITDA of ₹2.58 Cr (EBITDA margin 17%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 28% over five years.

The company has about 44 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: S3V Vascular Technologies. As per MCA filings, the company has open charges of ₹181 Cr and satisfied charges of ₹23.7 Lakh on record. Court records list 1 case involving the company, including 1 filed against it. The company has 31 deals on record (17 secondary share transfers, 10 funding rounds, 4 rights issues), with disclosed funding of ₹140.38 Cr; the latest was in March 2024. Its 10 peer companies in the Healthcare industry (Medical and Laboratory Equipment) are compared by revenue, 5 larger and 5 smaller; the largest is Sanma Medineers Vision Private Limited with revenue of ₹15.52 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website s3vvascular.com.

Company Details of S3v Vascular Technologies Limited
CIN U33112KA2011PLC059915
Registration Number 059915
Incorporation Date 09 August 2011
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 November 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Plot No. 65/D4 Hootagalli Industrial Area Hootagalli, Mysore, Karnataka, India – 570018
  • Industry
    Healthcare, Medical & Laboratory Equipment
Comprehensive company report
S3v Vascular Technologies Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full S3v Vascular Technologies Limited report

Financials, compliance, directors, charges, ownership and filings for S3v Vascular Technologies Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of S3v Vascular Technologies Limited

The main business activity of S3v Vascular Technologies is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of S3v Vascular Technologies Limited FY 2025 filings available

S3v Vascular Technologies Limited reported revenue of ₹15.15 Cr (down 20% YoY) for FY 2024.

Revenue · FY 2024
₹15.15 Cr ▼ 20%
Net loss · FY 2024
₹3.2 Cr margin -21.1%
EBITDA · FY 2024
₹2.58 Cr margin 17%

Compounded Annual Growth Rate (CAGR) of S3v Vascular Technologies Limited

Revenue CAGR growth
1 year
▼ 20%
3 years · compounded
▼ 3%
5 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 21%
5 years · compounded
▲ 26%

Revenue fell 20% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 28%. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of S3v Vascular Technologies Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹2.58 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹3.2 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of S3v Vascular Technologies Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin17%••••••••••••••••
Net Profit Margin-21.1%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of S3v Vascular Technologies are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of S3v Vascular Technologies Limited

S3v Vascular Technologies Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sanma Medineers Vision Private Limited₹15.52 Cr (FY 2025)••••••••145.0%••••Chennai, Tamil Nadu, India
Instalimb India Private Limited₹15.35 Cr (FY 2025)••••••••756.0%••••Haryana, India
Amson Biomed Private Limited₹15.34 Cr (FY 2025)••••••••62.0%••••Ahmedabad, Gujarat, India
Primelaze Private Limited₹15.34 Cr (FY 2024)••••••••-1.0%••••Puducherry, India
QNQ Design and Development Private Limited₹15.33 Cr (FY 2024)••••••••112.0%••••New Delhi, Delhi, India
S3v Vascular Technologies Limited this company₹15.15 Cr (FY 2024)••••••••-20.0%••••Mysore, Karnataka, India
Deepak Care Limited₹15.13 Cr (FY 2024)••••••••-25.0%••••New Delhi, Delhi, India
Radion Equipments Private Limited₹15.09 Cr (FY 2024)••••••••8.0%••••Bangalore, Karnataka, India
Samrudhdi Health Equipments Private Limited₹15.05 Cr (FY 2025)••••••••-21.0%••••Mumbai, Maharashtra, India
Confluent Medical Technologies India Private Limited₹15.03 Cr (FY 2025)••••••••-32.0%••••Patancheru, Telangana, India
Cistron Systems Pvt Ltd₹15.01 Cr (FY 2025)••••••••14.0%••••Secunderabad, Telangana, India

Peers are the five companies nearest above and the five nearest below S3v Vascular Technologies by revenue in the Healthcare industry (Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of S3v Vascular Technologies Limited

S3v Vascular Technologies Limited is audited by P Murali & Co., for the financial year 2022.

NameStatusAppointment DateCessation Date
P Murali & Co.,LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of S3v Vascular Technologies Limited

S3v Vascular Technologies Limited currently reports 9 directors and 1 key managerial person. 18 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Dip Sen KishoreNominee Director15 Apr 20242 Years 6 MonthsCurrent
Prithi Sureka MummidiDirector09 Jun 20224 Years 4 MonthsCurrent
Veeresham CiddiDirector06 Jun 20224 Years 4 MonthsCurrent
Nagarada Gadde Vishnu ShreyasWhole-Time Director13 Aug 20188 Years 2 MonthsCurrent
Govindan RamaswamyDirector15 Apr 20242 Years 6 MonthsCurrent
Venkateswara Gowtama MannavaDirector10 Nov 20223 Years 11 MonthsCurrent
Showing 6 of 10 current directors and KMP. View all directors and KMP

Ownership and Shareholding of S3v Vascular Technologies Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of S3v Vascular Technologies Limited

Open charges
₹181 Cr
Satisfied charges
₹23.7 Lakh
Breakdown by lending institutions
Others₹112.79 Cr
Indian Overseas Bank₹68.22 Cr
Latest charge details
DateLenderAmountStatus
29 May 2025Others₹99.76 CrOpen
14 May 2025Indian Overseas Bank₹10.5 LakhOpen
24 Mar 2023Indian Overseas Bank₹34 LakhOpen
09 May 2017Others₹13.03 CrOpen
06 Jul 2013Indian Overseas Bank₹67.77 CrOpen

Total charge records: 8 View all charges

Deals & Funding of S3v Vascular Technologies Limited

S3v Vascular Technologies Limited has 31 deals on record (17 secondary share transfers, 10 funding rounds, 4 rights issues), with disclosed funding of ₹140.38 Cr; the latest was in March 2024.

Total deals
31
Secondary share transfers
17
Funding rounds
10
Rights issues
4
Disclosed funding
₹140.38 Cr

Deals on record (5 of 31)

WhenDealAmountParties
Mar 2024Funding round₹98.37 CrInvestors: L&T Welfare Company Limited, Mahima Stocks Private Limited , 2 individuals
Aug 2021Funding round₹12.6 CrInvestors: 4 individuals
Feb 2021Rights issue₹1.83 CrInvestors: Swarnim Avenues Private Limited , 3 individuals
Jan 2021Rights issue₹5.32 CrInvestors: 4 individuals
Aug 2020Secondary share transferUndisclosedBuyer: DLM Estates LLP , Shivam Ventures, an individual
Seller: Marvel Investment, 2 individuals
Premium access

Full deal history

All 31 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Associated Brands with S3v Vascular Technologies Limited

S3v Vascular Technologies operates one associated brand: S3V Vascular Technologies. Each brand links to its own profile.

BrandDescriptionWebsite
Cardiovascular surgical and critical care devices are developed and offered.s3vvascular.com

Employees and EPFO Compliance at S3v Vascular Technologies Limited

S3v Vascular Technologies Limited has a workforce of 44 employees as of Apr 09, 2024.

Employee count
44
Active EPFO establishments
1
Employee growth
-4.35%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

CIN History of S3v Vascular Technologies Limited

S3v Vascular Technologies has one previous CIN (Corporate Identification Number): U33112KA2011PTC059915. The current CIN is U33112KA2011PLC059915, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U33112KA2011PLC059915Current
U33112KA2011PTC059915Previous

Recent Activity on S3v Vascular Technologies Limited

S3v Vascular Technologies Limited has 26 board changes on record since 2011: 11 appointments and 15 cessations. The latest: Nallapeta Anandakumar Nagashanmukha was appointed as Company Secretary on 26 May 2025.

AGM
S3V Vascular Technologies Limited last Annual general meeting of members was held on 29 Nov 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 99.76 Cr with Charge ID 101104011 was registered on 29 May 2025.
Appointed
Nallapeta Anandakumar Nagashanmukha was appointed as Company Secretary.
Charges
A charge registered on 16 Nov 2021 via Charge ID 100501373 with Indian Overseas Bank was fully satisfied on 16 May 2025.
Charges
A charge registered on 16 Nov 2021 via Charge ID 100501386 with Indian Overseas Bank was fully satisfied on 16 May 2025.
Charges
A charge registered on 16 Nov 2021 via Charge ID 100501400 with Indian Overseas Bank was fully satisfied on 16 May 2025.
Charges
A charge with Indian Overseas Bank amounted to Rs. 0.11 Cr with Charge ID 101102584 was registered on 14 May 2025.
Filing
S3V Vascular Technologies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Dip Sen Kishore ceased to be Additional Director.
Ceased
Govindan Ramaswamy ceased to be Additional Director.
Appointed
Dip Sen Kishore was appointed as Nominee Director.
Appointed
Govindan Ramaswamy was appointed as Director.

29 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for S3v Vascular Technologies Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by S3v Vascular Technologies Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of S3v Vascular Technologies Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of S3v Vascular Technologies Limited

S3v Vascular Technologies has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
29AAQCS2303F1ZCKarnatakaActive01 Jul 2017
36AAQCS2303F1ZHTelanganaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of S3v Vascular Technologies Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about S3v Vascular Technologies Limited

S3v Vascular Technologies is an active public limited company based in Mysore, Karnataka, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 09 August 2011 (15+ years old) and is registered under CIN U33112KA2011PLC059915.

S3v Vascular Technologies reported revenue of ₹15.15 Cr for FY 2024 (down 20% YoY).

S3v Vascular Technologies has 10 current directors and KMP:

S3v Vascular Technologies reported a net loss of ₹3.2 Cr (net margin -21.1%) and EBITDA of ₹2.58 Cr (EBITDA margin 17%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of S3v Vascular Technologies is -3% over three years and 28% over five years. In the latest year (FY 2024) revenue fell 20%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of S3v Vascular Technologies is 29AAQCS2303F1ZC, registered in Karnataka. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAQCS2303F1ZH (Telangana).

The CIN (Corporate Identification Number) of S3v Vascular Technologies is U33112KA2011PLC059915. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

S3v Vascular Technologies has 1 court case on record: 1 filed against it.

S3v Vascular Technologies was incorporated on 09 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Bangalore.

S3v Vascular Technologies has 31 deals on record (17 secondary share transfers, 10 funding rounds, 4 rights issues), with disclosed funding of ₹140.38 Cr; the latest was in March 2024.

The peers of S3v Vascular Technologies by revenue are Sanma Medineers Vision Private Limited, Instalimb India Private Limited, Amson Biomed Private Limited, Primelaze Private Limited, QNQ Design and Development Private Limited and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available